You are here: Home: Meet The Professors Vol. 1 2004: CME Information
Meet the Professors: A case-based discussion on the management of women with metastatic breast cancer
STATEMENT OF NEED/TARGET AUDIENCE
Breast cancer is one of the most rapidly evolving fields in medical oncology. Published results from a plethora of ongoing clinical trials lead to the continuous emergence of new therapeutic agents and changes in the indications for existing treatments. In order to offer optimal patient care — including the option of clinical trial participation — the practicing medical oncologist must be well informed of these advances. In order to incorporate research advances into developing treatment strategies for patients, the CME program, Meet the Professors, utilizes case-based discussions between community oncologists and research leaders.
LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:
- Describe and implement a management strategy integrating chemotherapy, endocrine therapy and biologic therapy into the treatment of metastatic breast cancer in women.
- Determine the clinical implications of emerging data on the use of trastuzumab in combination with chemotherapy in the management of HER2-positive, metastatic breast cancer in women.
- Determine the adjuvant and neoadjuvant role of chemotherapy for patients diagnosed with locally advanced breast cancer.
- Discuss the use of sequential single-agent versus combination chemotherapy for the treatment of metastatic breast cancer.
EDUCATIONAL METHOD
To receive CME credit, the participant should listen to the CDs or tapes, review the monograph and complete the post-test and evaluation form.
ACCREDITATION STATEMENT
Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
Research To Practice designates this educational activity for a maximum of 4 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent on the activity.
|
